Debarment of Applicants Submitting Misleading, Fake, or Fabricated Documents under the Drugs Rules, 1945

The Drugs (Eleventh Amendment) Rules, 2026 amend the Drugs Rules, 1945 by introducing a formal definition of “debarment” and inserting debarment provisions across multiple licensing and regulatory parts of the Rules. Under the amendment, any person, firm, entity, or applicant found guilty of submitting misleading, fake, or fabricated documents or information may be debarred by the Licensing Authority or Central Licensing Approving Authority for a period considered appropriate after being given an opportunity to show cause. The amendment applies across provisions relating to import, manufacture, sale, distribution, and other regulated drug activities. Applicants affected by a debarment order may file an appeal before the concerned Government within thirty days of receiving the order. The objective is to strengthen regulatory compliance, promote data integrity, and deter submission of false information during licensing and approval processes.